Nifty
Sensex
:
:
24213.30
79476.63
217.95 (0.91%)
694.39 (0.88%)

Trading

Rating :
N/A

BSE: 544143 | NSE: Not Listed

199.2
05-Nov-2024
  • Open
  • High
  • Low
  • Previous Close
  •  195.3
  •  199.2
  •  195.3
  •  189.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4000
  •  789000
  •  233.10
  •  103.53

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 97.61
  • 58.52
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 90.47
  • N/A
  • 5.10

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.96%
  • 4.53%
  • 21.88%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 5.63%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Net Sales
-
17.80
Net Sales Growth
-
 
Cost Of Goods Sold
-
14.63
Gross Profit
-
3.17
GP Margin
-
17.81%
Total Expenditure
-
15.53
Power & Fuel Cost
-
0.01
% Of Sales
-
0.06%
Employee Cost
-
0.43
% Of Sales
-
2.42%
Manufacturing Exp.
-
0.00
% Of Sales
-
0%
General & Admin Exp.
-
0.22
% Of Sales
-
1.24%
Selling & Distn. Exp.
-
0.14
% Of Sales
-
0.79%
Miscellaneous Exp.
-
0.10
% Of Sales
-
0.56%
EBITDA
-
2.27
EBITDA Margin
-
12.75%
Other Income
-
0.03
Interest
-
0.09
Depreciation
-
0.01
PBT
-
2.20
Tax
-
0.61
Tax Rate
-
27.73%
PAT
-
1.59
PAT before Minority Interest
-
1.59
Minority Interest
-
0.00
PAT Margin
-
8.93%
PAT Growth
-
 
EPS
-
3.24

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Shareholder's Funds
18.22
Share Capital
4.90
Total Reserves
13.32
Non-Current Liabilities
0.00
Secured Loans
0.00
Unsecured Loans
0.00
Long Term Provisions
0.00
Current Liabilities
2.55
Trade Payables
0.05
Other Current Liabilities
0.89
Short Term Borrowings
1.60
Short Term Provisions
0.00
Total Liabilities
20.77
Net Block
0.05
Gross Block
0.06
Accumulated Depreciation
0.01
Non Current Assets
0.59
Capital Work in Progress
0.00
Non Current Investment
0.42
Long Term Loans & Adv.
0.12
Other Non Current Assets
0.00
Current Assets
20.18
Current Investments
0.00
Inventories
4.15
Sundry Debtors
3.22
Cash & Bank
8.74
Other Current Assets
4.08
Short Term Loans & Adv.
4.05
Net Current Assets
17.63
Total Assets
20.77

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Cash From Operating Activity
-3.87
PBT
2.20
Adjustment
0.04
Changes in Working Capital
-5.50
Cash after chg. in Working capital
-3.26
Interest Paid
0.00
Tax Paid
-0.61
Other Direct Exp. Paid
0.00
Extra & Other Items
0.00
Cash From Investing Activity
-0.52
Net Fixed Assets
Net Investments
Others
Cash from Financing Activity
13.13
Net Cash Inflow / Outflow
8.74
Opening Cash & Equivalents
0.00
Closing Cash & Equivalent
8.74

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Book Value (Rs.)
37.19
ROA
7.65%
ROE
8.72%
ROCE
11.55%
Fixed Asset Turnover
283.89
Receivable days
66.00
Inventory Days
85.07
Payable days
1.36
Cash Conversion Cycle
149.71
Total Debt/Equity
0.09
Interest Cover
24.64

Annual Reports:

News Update:


  • Royal Sense launches new product ‘Stergic Dengue IgG/IgM Rapid Test’
    26th Aug 2024, 12:52 PM

    This new products available for sale from August 23, 2024

    Read More
  • Royal Sense launches new product ‘Stergic Chikungunya IgG/IgM Rapid Test’
    21st Aug 2024, 16:00 PM

    The Chikungunya rapid test is a diagnostic tool designed to detect the presence of Chikungunya virus antibodies in a blood sample

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.